Ceribell, Inc., the developer of the first AI-powered point-of-care EEG diagnostic system, is revolutionizing seizure management in acute care. Their mission is to establish the Ceribell System as the standard of care for EEG in the acute care setting and help clinicians save patient lives. Ceribell is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. They have developed the Ceribell System, a novel, point-of-care electroencephalography (“EEG”) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, highly portable, and rapidly deployable hardware with sophisticated artificial intelligence (“AI”)-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.
“The Ceribell EEG technologies have improved our ability to detect and treat seizures it’s readily available, it’s in the ICU, it’s in the emergency department.”
“It’s just made a huge difference as far as the timing and being able to rapidly assess and treat appropriately and to really triage the brain in a way that …
“Instead of intubating the patient, sending them to the ICU, expending those efforts, this patient never saw the neuro ICU. They were discharged home.”
Read Ceribell Reviews, Testimonials & Customer References from 6 real Ceribell customers.
Watch Ceribell Customer Videos to learn why 6 businesses chose Ceribell.
FeaturedCustomers has 1,899,738+ validated customer references
including reviews, case studies, success stories, customer stories,
testimonials and customer videos that will help you make better
software purchasing decisions.
